The safety of allergen immunotherapy: A literature review

Ear, Nose and Throat Journal

Volumn 77, Issue 5, 1998, Pages 378-388

  Cook, Paul R ^a,b   Farias, Carlos ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; POLLEN ANTIGEN;

ALLERGIC REACTION; DELAYED HYPERSENSITIVITY; FATALITY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOTHERAPY; PREMEDICATION; PRURITUS; REVIEW; RISK FACTOR; RISK MANAGEMENT; SAFETY; SKIN TEST; URTICARIA;

EID: 0031749825     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556139807700510     Document Type: Review

References (29)

1. Noon L. Prophylactic inoculation against hay fever. Lancet 1911;1:572.
2. Freeman J. Further observations on the treatment of hayfever by hypodermic inoculation of pollen vaccine. Lancet 1911;2:814.
3. Curtis HH. The immunizing cure for hay fever. Med News 1900;77:16.
4. Lamson RW. So-called fatal anaphylaxis in man. JAMA 1929;93:1975-78.
5. Lockey RF, Benedict LM, Turkeltaub PC, et al. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987;79(4)660-7.
6. Norman PS, VanMetre TE. The safety of allergenic immunotherapy. J Allergy Clin Immunol 1990;85(2):522-5.
7. Davis WE, Cook PR, McKinsey JP, et al. Anaphylaxis in immunotherapy, Otolaryngol Head Neck Surg 1992;107:78-83.
8. Reid MJ, Lockey, RF, Turkeltaub PC, et al. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993;92(Pt.1):6-15.
9. Van Arsdel PP, Sherman WB. The risk of inducing constitutional reactions in allergic patients. J Allergy 1957;28(3):251-61.
10. Greenburg MA, Kaufman CR, Gonzalez GE, et al. Late and immediate systemic-allergic reaction to inhalant allergen immunotherapy. J Allergy Clin Immunol 1986;77(6):865-70.
11. Cooke RA. Studies in specific hypersensitivity III: The dangers of the diagnostic cutaneous test and therapeutic injection of allergens. J Immunol 1922;7(119):119-46.
12. Vervloet D, Khairallah E, Arnaud A, et al. Prospective national study of the safety of immunotherapy. Clin Allergy 1980;10:59.
13. Ranson JH. Frequency of reactions to alum-precipitated ragweed extract. Ann Allergy 1971;29:635.
14. Kaufman CR, Summers RJ, Renard RL. Safety of immunotherapy: A prospective study. Ann Allergy 1984;52:220-6.
15. Levine MI. Systemic reactions to immunotherapy. J Allergy Clin Immunol 1979;63:209.
16. Figley KD. The continuous method of hayfever treatment. J Allergy 1931;2:39.
17. Furstonberg FF, Gay LN. The occurrence of constitutional reactions in the treatment of hayfever and asthma: Analysis of corrective factors. Bull Johns Hopkins 1937;60:412.
18. Iliopoulos O, Proud D, Adkinson NF, Jr., et al. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: Changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87(4):855-66.
19. Furin MJ, Norman PS, Creticos PS, et al. Immunotherapy decreases antigen induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunology 1991;88(1):364-72.
20. Lin MS, Tanner E, Lynn J, et al. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 1993;71:557-62.
21. Tinkelman DG, Cole WQ, Tunno J, Immunotherapy: A one-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 1995;95(1: Pt 1):8-14.
22. Cook PR, Bryant JL, Davis WE, et al. Systemic reactions to immunotherapy. The AAOA Morbidity and Mortality Survey. Otolaryngol Head Neck Surg 1994;110(6):487-93.
23. Gordon BR. Allergy skin test and immunotherapy: Comparisons of methods in common use. Ear Nose Throat J 1990;69:47-61.
24. Willoughby JW. New concepts in immunotherapy. Otolaryngol Clin North Am 1992;25(1):71-100.
25. Ward WA. Immunotherapy dosage based on skin endpoint titration. In: Mabry, RL (ed). Skin endpoint titration (AAOA monograph series). New York: Thieme Medical Publications, 1992:39-42.
26. King HC. Endpoint titration and immunotherapy. Otolaryngol Clin North Am 1985;18:703-17.
27. Greineder DK. Risk management in allergen immunotherapy. J Allergy Clin Immunol 1996;98:S330-4.
28. Kay AB. Allergen injection immunotherapy (hypersensitization on trial). Clin Exper Allergy 1989;19:591-6.
29. Gordon BR. Immunotherapy: Rationale and mechanisms. Otolaryngol Head Neck Surg 1992;107(6:Pt.2):861-5.